VNTXF
VANTA HOLDINGS INC.$0.6000 +0.00 (+0.00%)
Oct 23 4:00 PM ET · prev $0.6000
1 year
−25.0%
from $0.8000 · Oct 27
30 days
0.0%
from $0.6000
52-week range
$0.2500–1.80
−67% from high · low Nov 5
Avg volume 20D
0
Sep 28 spike 0
Price
Daily candles with volume.
No data for this timeframe.
Signal stack
Where each data set points today.
- TrendRANGE
15% below its 50-day average.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 6, 2026 Event
Nalocet
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF OXYCODONE AND ACETAMINOPHEN TABLETS Addictio
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 6, 2026
FDA
Nalocet
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF OXYCODONE AND ACETAMINOPHEN TABLETS Addiction, Abuse, and Misuse Because the use of oxycodone
Aug 6, 2026
FDA
Nalocet
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF OXYCODONE AND ACETAMINOPHEN TABLETS Addiction, Abuse, and Misuse Because the use of oxycodone
Aug 6, 2026
FDA
Nalocet
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF OXYCODONE AND ACETAMINOPHEN TABLETS Addiction, Abuse, and Misuse Because the use of oxycodone
Jul 28, 2026
FDA
Prolate
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN ORAL SOLUTION Risk of Medication Errors Ensure accur